Investment
Features
FeesSafety
Academy
More
Pluang+

Compare uniQure N.V. Ordinary Shares (QURE) vs J M Smucker Co (SJM) Price & Performance

uniQure N.V. Ordinary SharesTrade
J M Smucker CoTrade

Price performance (Past 24H)

Key statistics

uniQure N.V. Ordinary Shares vs J M Smucker Co — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while J M Smucker Co trades at $122 (market cap $12.96B). The key difference: J M Smucker Co is far larger — about 8.8× uniQure N.V. Ordinary Shares's market cap, and J M Smucker Co pays a 3.69% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and J M Smucker Co for 74 Days on average.

QURESJM
Market Cap
$1.48B$12.96B
Volume
2,488,7801,039,289
Sector
HealthConsumer Staples
52-Week High
$70.59$132.34
52-Week Low
$9.03$89.53
Typical Hold Time
0 Days74 Days
Enterprise Value
$728.62M$19.81B
Dividend Yield
—3.69%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

J M Smucker Co

SJM trades at $121.84, up 1.52% today, with a bullish technical signal and strong recent earnings beats. The company reported Q2 2026 EPS of $3.24, beating expectations, and raised FY27 guidance. However, 2025 fundamentals show a net loss of $1.23B and elevated P/E of 56.7, while analyst consensus is a Buy with a $138.23 price target.

Outlook is mixed; robust growth in segments like Uncrustables and raised guidance support upside, but high valuation, volatile profitability, and debt levels pose risks. The stock offers a dividend yield but faces competitive and margin pressures in the consumer staples sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QURE
100% Buy0% Sell
Avg holding period · 0 Days
SJM

No sentiment data available yet.

Top news

Latest headlines on both assets

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →

About J M Smucker Co

J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.

Read more on SJM →